CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Cash Flow Report and Market Update 30 Sep 2020, page-2

  1. 3,320 Posts.
    lightbulb Created with Sketch. 1155
    Good update. This has some serious potential with commercialisation of DermaCann in the US not very far away now.

    Low number of shares on issue, low market cap - these are the ones that explode when the pieces of the puzzle drop into place.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.